MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from
divestiture, net of cash...
$90,204K
Net cash provided by
investing activities
$87,160K
Canceled cashflow
$3,044K
Net increase in cash
and cash...
-$1,866K
Canceled cashflow
$87,160K
Net income (loss)
$200,636K
Loss on debt
extinguishments
-$6,583K
Dividend received from
unconsolidated variable...
$3,947K
Prepaid expenses and
other current assets
-$3,295K
Accrued interest
expense related to sale...
$1,975K
Inventories
-$1,030K
Stock-based compensation
$662K
Accounts receivable, net
-$552K
Other long-term
liabilities
$311K
Operating lease
right-of-use assets
-$188K
Depreciation
$183K
Amortization of finance lease
right-of-use assets
$9K
Operating lease
liabilities, non-current
$3K
Net accretion of
premium and discount on...
-$2K
Purchases of
available-for-sale securities
$3,035K
Purchases of property and
equipment
$9K
Net cash used in
financing activities
-$85,917K
Net cash provided by
(used in) operating...
-$1,847K
Effect of exchange rate
change on cash and cash...
-$1,262K
Canceled cashflow
$219,376K
Repayments of senior
secured term loan...
$75,000K
Payment of senior
secured term loan...
$5,550K
Cash paid to
non-controlling interest
$5,353K
Cash paid for payroll
taxes on restricted...
$12K
Repayments of finance lease
liabilities
$2K
Deferred revenues
-$143,858K
Gain on divestiture
$52,163K
Accrued and other
liabilities
-$17,448K
Accounts payable
-$4,614K
Other assets
$1,621K
Investment income in
unconsolidated variable...
$1,377K
Operating lease
liabilities, current
-$134K
Accrued interest for
finance lease...
-$8K
Back
Back
Cash Flow
source: myfinsight.com
FIBROGEN INC (FGEN)
FIBROGEN INC (FGEN)